Abstract Purpose of Review Diabetes mellitus is a global epidemic which is growing in
prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment …

Elevation of intraocular pressure (IOP) due to therapeutic use of glucocorticoids is called
steroid-induced ocular hypertension (SIOH); this can lead to steroid-induced glaucoma …

Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite
that DME represents a sight‐threatening condition, it is also among the most accessible to …

Over the past decade, great strides have been made in the management of diabetic macular
edema (DME). Therapeutic alternatives now include focal/grid laser photocoagulation, vitreo …

Aims: Retinal pharmacotherapy has gained great importance for the treatment of various
retinal diseases. An increasing number of drugs have been constantly released into the …

Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-
vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments …

Background: Diabetic macular edema (DME), cystoid macular edema (CME), age-related
macular degeneration (AMD), retinal vascular occlusion (RVO) and uveitis are responsible …

Background Visualizing vitreous and retinal surface during vitrectomy, choromovitrectomy, is
a novel approach in vitrectomy. Methods Triamcinolone acetonide (TA) is now most …

Purpose: To determine if potentially viable alternatives to the clinical use of intravitreal
triamcinolone acetonide should be considered based on a comparative assessment of the in …

Diabetic macular edema (DME) remains an important cause of visual loss worldwide.
Corticosteroids have a role in the treatment of some patients with advanced or recurrent …